Predicting prognosis and drug sensitivity in patients with hepatocellular carcinoma using an lncRNA signature associated with cuproptosis

Abstract Background Hepatocellular carcinoma (HCC) is a prevalent type of malignant tumor known for its aggressive proliferation and invasive behavior. The exact molecular mechanisms underlying HCC development and progression remain unclear. Nevertheless, cuproptosis has been linked to a range of di...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Yan Li, Shiyu Lv, Yunqiu Wang
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2026-05-01
Schriftenreihe:	BMC Cancer
Schlagworte:	Hepatocellular carcinoma LncRNA Cuproptosis Prognosis Drug sensitivity Biomarker
Online-Zugang:	https://doi.org/10.1186/s12885-026-16132-w
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!